<b>Conclusions:</b> This study defines a novel OTUD7B-SERCA2a regulatory axis and identifies OTUD7B as a promising therapeutic target for cardiac hypertrophy and dysfunction. Here, OTUD7B is linked to cardiac hypertrophy.